STAT3 and glioblastoma: Similarly, STAT3 inhibitors can significantly inhibit the growth and differentiation of GBM cells under in vitro conditions, but the inhibitory effects of STAT3 inhibitors on tumors under in vivo conditions were not pronounced (Han et al., 2019).